LEAS FOUNDATION FOR LEUKEMIA RESEARCH (EIN 061520923) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1998

Legal Domicile

Phone

8602431428

Tax Period

2024-08-01 to 2025-07-31

LEAS FOUNDATION FOR LEUKEMIA RESEARCH, founded in 1998, is a small nonprofit in the Diseases & Disorders sector that reported $231K in total revenue in fiscal year 2024. Revenue fell 57% from the prior year — a significant decline worth monitoring. Expenses of $208K left a modest 10% surplus.

Mission

Lea's Foundation was established to fund research into the causes and/or cures for Leukemia and its related cancers of Lymphoma, Hodgkin's Lymphoma, and Multiple Mylemoa. Additionally the Foundation provides financial assistance to patients affected by Leukemia and similar malignant blood-related diseases. The Foundation further provides increased public awareness of these cancers through its participation and support of community health programs.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $34,783

Program Service Revenue $0

Investment Income $36,020

Other Revenue $160,052

TOTAL REVENUE $230,855

Expense Breakdown

Grants Paid $127,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $194,783

Other Expenses $81,166

TOTAL EXPENSES $208,166

Year-over-Year Comparison

	2024	2023	Change
Revenue	$230,855	$531,534	-0.6%
Expenses	$208,166	$97,411	+1.1%
Net Income	$22,689	$434,123	-0.9%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
David Archilla	Chairman	2.00	Officer Director	$0	$0	$0
George Economos	Vice Chairman	2.00	Officer Director	$0	$0	$0
David Smith	Director	2.00	Director	$0	$0	$0
Gary Laurito	President	3.00	Officer Director	$0	$0	$0
Lea Bradley	Secretary	2.00	Officer Director	$0	$0	$0
Kevin Bingham	Director	0.00	Director	$0	$0	$0
Maria Economos	Director	2.00	Director	$0	$0	$0
Mark Espinosa	Director	0.00	Director	$0	$0	$0
Morgan Hilliard	Director	0.00	Director	$0	$0	$0
Jason Frechette	Director	0.00	Director	$0	$0	$0
Carla Economos	Vice President	0.00	Director	$0	$0	$0
Steven Norris	Director	0.00	Director	$0	$0	$0
Ashley Goncalves	Director	0.00	Director	$0	$0	$0
Nicholas Stamboulis	Director	0.00	Director	$0	$0	$0
Penny Wills	Treasurer	3.00	Director	$0	$0	$0
Kris Young	Director	0.00	Director	$0	$0	$0
Vann Young	Director	0.00	Director	$0	$0	$0
Satya Chhabra	Director	0.00	Director	$0	$0	$0
Michael Goncalves	Director	0.00	Director	$0	$0	$0
Corey Laurito	Director	0.00	Director	$0	$0	$0
Ryan Leichsenring	Director	0.00	Director	$0	$0	$0
Andy Kulas	Director	0.00	Director	$0	$0	$0
Bess Economos	Assoc Director	0.00	Director	$0	$0	$0
Robert Storm	Assoc Director	0.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$230,855	$208,166	$1,877,295	$22,689
2024	$531,534	$97,411	$1,852,392	$434,123
2023	$275,524	$110,230	$1,506,166	$165,294
2022	$97,815	$122,727	$1,449,631	$-24,912
2022	$97,815	$122,727	$1,449,631	$-24,912
2021	$231,076	$68,707	$1,549,934	$162,369
2020	$302,836	$174,105	$1,423,512	$128,731
2019	$314,998	$395,838	$1,376,345	$-80,840

LEAS FOUNDATION FOR LEUKEMIA RESEARCH